Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

ABBV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.25%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $130,132,002.24

AbbVie Insider Trading History Chart

AbbVie Share Price & Price History

^$201.46

▲ +0.99 (0.49%)

As of 11/5/2024 02:51 PM ET

Days: 30 | 90 | 365

625,000% Gain

From Crypto Swap Profits | Ad

>> Dive into the Workshop Here

AbbVie Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/5/2024	Richard A. Gonzalez	Chairman	Sell	66,500	$186.52	$12,403,580.00	446,599
7/17/2024	Richard A. Gonzalez	Chairman	Sell	282,845	$175.00	$49,497,875.00	513,099
3/20/2024	Nicholas Donoghoe	EVP	Sell	21,082	$176.30	$3,716,756.60	55,903
3/18/2024	Jeffrey Ryan Stewart	EVP	Sell	58,949	$178.79	$10,539,491.71	60,941
2/29/2024	Kevin K Buckbee	SVP	Sell	5,144	$176.65	$908,687.60	6,983
2/29/2024	Perry C Siatis	EVP	Sell	9,891	$177.39	$1,754,564.49	10,397
2/29/2024	Robert A. Michael	COO	Sell	68,879	$176.45	$12,153,699.55	98,645
2/28/2024	Richard A. Gonzalez	CEO	Sell	138,616	$177.27	$24,572,458.32	519,099
2/23/2024	Perry C Siatis	EVP	Sell	13,753	$177.51	$2,441,295.03	28,173
2/23/2024	Scott T. Reents	CFO	Sell	14,140	$177.44	$2,509,001.60	27,065
2/21/2024	Azita Saleki-Gerhardt	EVP	Sell	52,870	$173.71	$9,184,047.70	243,944
12/26/2023	Nicholas Donoghoe	EVP	Sell	2,912	$154.72	$450,544.64	55,903
7/31/2023	Richard A. Gonzalez	CEO	Sell	18,500	$149.15	$2,759,275.00	625,294
4/25/2023	Elaine K. Sorg	SVP	Sell	6,130	$165.00	$1,011,450.00	35,330
4/17/2023	Elaine K. Sorg	SVP	Sell	7,499	$161.67	$1,212,363.33	35,330
4/3/2023	Elaine K. Sorg	SVP	Sell	15,002	$160.03	$2,400,770.06	42,829
4/3/2023	Perry C Siatis	EVP	Sell	3,520	$160.00	$563,200.00	10,377
3/13/2023	Jeffrey Ryan Stewart	EVP	Sell	53,125	$152.28	$8,089,875.00	60,941
3/1/2023	Elaine K. Sorg	SVP	Sell	15,003	$155.00	$2,325,465.00	42,829
3/1/2023	Perry C Siatis	EVP	Sell	12,135	$153.08	$1,857,625.80	10,377
3/1/2023	Scott T. Reents	CFO	Sell	15,942	$153.08	$2,440,401.36	809
2/21/2023	Carrie C. Strom	SVP	Sell	28,541	$151.04	$4,310,832.64	37,921
2/17/2023	Azita Saleki-Gerhardt	EVP	Sell	25,000	$149.53	$3,738,250.00	233,208
2/17/2023	Roxanne S. Austin	Director	Sell	10,000	$150.50	$1,505,000.00	40,705
12/12/2022	Timothy J. Richmond	EVP	Sell	42,370	$163.44	$6,924,952.80	13,837
5/23/2022	Michael Severino	Vice Chairman	Sell	79,801	$150.90	$12,041,970.90	152,103
5/16/2022	Henry O Gosebruch	EVP	Sell	83,960	$155.00	$13,013,800.00	16,623
5/16/2022	Michael Severino	Vice Chairman	Sell	100,000	$154.45	$15,445,000.00	152,103
5/9/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.28	$15,028,000.00	152,103
5/6/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.81	$15,081,000.00	152,103
3/24/2022	Jeffrey Ryan Stewart	EVP	Sell	27,690	$159.20	$4,408,248.00
3/9/2022	Brian L. Durkin	VP	Sell	18,628	$150.01	$2,794,386.28
3/1/2022	Henry O Gosebruch	EVP	Sell	15,000	$148.26	$2,223,900.00
3/1/2022	Robert A. Michael	Vice Chairman	Sell	43,105	$148.25	$6,390,316.25
2/7/2022	Carrie C. Strom	SVP	Sell	2,396	$141.17	$338,243.32
12/20/2021	Brian L. Durkin	VP	Sell	11,790	$128.51	$1,515,132.90
12/17/2021	Laura J. Schumacher	Vice Chairman	Sell	181,670	$130.24	$23,660,700.80
12/15/2021	Jeffrey Ryan Stewart	EVP	Sell	2,152	$128.00	$275,456.00
12/13/2021	Elaine K. Sorg	SVP	Sell	6,458	$125.85	$812,739.30
12/9/2021	Richard A. Gonzalez	CEO	Sell	174,100	$123.23	$21,454,343.00
12/6/2021	Timothy J. Richmond	EVP	Sell	50,350	$120.00	$6,042,000.00

NASDAQ traded stock with a BIG short position.

From Huge Alerts | Ad

Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!

See how this NASDAQ Bio-tech is offering viable solutions

SEC Filings (Institutional Ownership Changes) for AbbVie (NYSE:ABBV)

70.23% of AbbVie stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbbVie Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/5/2024	Harbour Investments Inc.	22,178	$4.38M	0.1%	-4.1%	0.001%
11/5/2024	Entropy Technologies LP	1,267	$0.25M	0.0%	N/A	0.000%
11/5/2024	Apollon Wealth Management LLC	71,021	$14.03M	0.4%	+3.8%	0.004%
11/5/2024	Jeppson Wealth Management LLC	9,821	$1.94M	0.7%	-0.9%	0.001%
11/5/2024	Everhart Financial Group Inc.	12,985	$2.56M	0.6%	+11.1%	0.001%
11/5/2024	Fountainhead AM LLC	1,452	$0.29M	0.1%	-4.3%	0.000%
11/5/2024	FDx Advisors Inc.	2,770	$0.55M	0.1%	-3.7%	0.000%
11/5/2024	Lynx Investment Advisory	1,711	$0.34M	0.2%	+6.3%	0.000%
11/5/2024	Nations Financial Group Inc. IA ADV	27,958	$5.52M	0.4%	+19.5%	0.002%
11/4/2024	Laffer Tengler Investments Inc.	56,528	$11.16M	2.3%	+2.6%	0.003%
11/4/2024	Loudon Investment Management LLC	22,039	$4.35M	2.4%	-4.0%	0.001%
11/4/2024	tru Independence LLC	18,472	$3.65M	1.1%	-47.8%	0.001%
11/4/2024	Venturi Wealth Management LLC	77,864	$15.38M	0.8%	+8.3%	0.004%
11/4/2024	Jaffetilchin Investment Partners LLC	8,938	$1.77M	0.1%	+9.5%	0.001%
11/4/2024	Core Wealth Partners LLC	3,884	$0.77M	0.5%	+27.8%	0.000%
11/4/2024	Riverpoint Wealth Management Holdings LLC	8,181	$1.62M	0.4%	+0.8%	0.000%
11/4/2024	Addison Advisors LLC	4,792	$0.95M	0.3%	-5.9%	0.000%
11/4/2024	United Capital Management of KS Inc.	24,550	$4.85M	1.1%	-13.9%	0.001%
11/4/2024	Catalytic Wealth RIA LLC	7,324	$1.45M	0.3%	-7.2%	0.000%
11/4/2024	Chartwell Investment Partners LLC	116,490	$23.01M	0.8%	-7.3%	0.007%
11/4/2024	Peregrine Asset Advisers Inc.	5,498	$1.09M	0.4%	+3.2%	0.000%
11/4/2024	Patten & Patten Inc. TN	185,936	$36.72M	2.4%	-1.2%	0.011%
11/4/2024	Paragon Capital Management LLC	1,049	$0.21M	0.1%	N/A	0.000%
11/4/2024	Ridgecrest Wealth Partners LLC	7,903	$1.56M	0.8%	+2.6%	0.000%
11/4/2024	Diamond Hill Capital Management Inc.	1,317,684	$260.22M	1.1%	-2.9%	0.075%
11/4/2024	Kennebec Savings Bank	9,115	$1.80M	1.8%	N/A	0.001%
11/4/2024	Ashton Thomas Securities LLC	1,942	$0.38M	0.1%	+21.5%	0.000%
11/4/2024	Los Angeles Capital Management LLC	615,498	$121.55M	0.5%	+163.9%	0.035%
11/4/2024	Arvest Investments Inc.	11,244	$2.22M	0.3%	+1.0%	0.001%
11/4/2024	Stockman Wealth Management Inc.	2,619	$0.52M	0.1%	-11.6%	0.000%
11/4/2024	Meritage Portfolio Management	33,535	$6.62M	0.4%	-1.8%	0.002%
11/4/2024	Crossmark Global Holdings Inc.	80,827	$15.96M	0.3%	+1.3%	0.005%
11/4/2024	Tyler Stone Wealth Management	4,469	$0.88M	0.2%	+131.9%	0.000%
11/4/2024	Migdal Insurance & Financial Holdings Ltd.	2,362	$0.47M	0.0%	-7.3%	0.000%
11/4/2024	Baker Avenue Asset Management LP	110,164	$21.76M	0.7%	+8.8%	0.006%
11/4/2024	Colonial River Investments LLC	8,098	$1.60M	0.8%	-7.9%	0.000%
11/4/2024	Mayflower Financial Advisors LLC	15,994	$3.16M	0.5%	-1.4%	0.001%
11/4/2024	Legacy Capital Wealth Partners LLC	4,469	$0.88M	0.1%	+9.1%	0.000%
11/4/2024	Axxcess Wealth Management LLC	64,748	$12.79M	0.3%	-4.1%	0.004%
11/4/2024	HTG Investment Advisors Inc.	1,050	$0.21M	0.1%	N/A	0.000%
11/4/2024	Alan B Lancz & Associates Inc.	5,624	$1.11M	1.0%	-2.6%	0.000%
11/4/2024	Liberty Wealth Management LLC	7,172	$1.42M	0.2%	-38.4%	0.000%
11/4/2024	Sigma Planning Corp	109,462	$21.62M	0.7%	-0.9%	0.006%
11/2/2024	Covestor Ltd	1,367	$0.27M	0.2%	+4.6%	0.000%
11/2/2024	ESL Trust Services LLC	342	$68K	0.0%	-21.9%	0.000%
11/2/2024	17 Capital Partners LLC	1,072	$0.21M	0.1%	N/A	0.000%
11/2/2024	Mach 1 Financial Group LLC	1,079	$0.21M	0.1%	-13.2%	0.000%
11/2/2024	Mesirow Financial Investment Management Inc.	165,212	$32.63M	0.6%	-0.8%	0.009%
11/2/2024	XML Financial LLC	14,194	$2.80M	0.3%	-1.1%	0.001%
11/2/2024	RKL Wealth Management LLC	15,411	$3.04M	0.3%	+105.2%	0.001%
11/1/2024	Carr Financial Group Corp	5,274	$1.04M	0.3%	+1.1%	0.000%
11/1/2024	Sheets Smith Wealth Management	15,163	$2.99M	0.4%	-2.3%	0.001%
11/1/2024	Proficio Capital Partners LLC	4,392	$0.87M	0.1%	-25.4%	0.000%
11/1/2024	Atria Investments Inc	170,620	$33.69M	0.4%	+1.8%	0.010%
11/1/2024	Essex Savings Bank	13,589	$2.68M	0.7%	+7.0%	0.001%
11/1/2024	Field & Main Bank	11,350	$2.24M	0.8%	-2.6%	0.001%
11/1/2024	Kerusso Capital Management LLC	6,658	$1.32M	0.8%	+6.5%	0.000%
11/1/2024	Oxbow Advisors LLC	7,032	$1.39M	0.1%	-4.4%	0.000%
11/1/2024	Objective Capital Management LLC	1,891	$0.37M	0.2%	N/A	0.000%
11/1/2024	SilverOak Wealth Management LLC	1,064	$0.21M	0.0%	N/A	0.000%
11/1/2024	Tompkins Financial Corp	33,771	$6.67M	0.6%	-7.8%	0.002%
11/1/2024	Scott & Selber Inc.	18,289	$3.61M	1.1%	-24.9%	0.001%
11/1/2024	TCTC Holdings LLC	139,679	$27.58M	0.9%	-1.8%	0.008%
11/1/2024	Carmel Capital Partners LLC	4,052	$0.80M	0.3%	-1.3%	0.000%
11/1/2024	Westchester Capital Management Inc.	105,590	$20.85M	5.1%	-1.0%	0.006%
11/1/2024	Lindbrook Capital LLC	11,499	$2.27M	0.2%	+2.4%	0.001%
11/1/2024	PFS Partners LLC	1,105	$0.22M	0.1%	-9.4%	0.000%
11/1/2024	5th Street Advisors LLC	1,400	$0.28M	0.1%	N/A	0.000%
11/1/2024	Bridges Investment Management Inc.	180,286	$35.60M	0.5%	-0.4%	0.010%
11/1/2024	Klingman & Associates LLC	11,665	$2.30M	0.1%	+35.7%	0.001%
11/1/2024	Wealth Quarterback LLC	1,641	$0.32M	0.2%	-19.6%	0.000%
11/1/2024	Nordwand Advisors LLC	482	$95K	0.0%	-74.4%	0.000%
11/1/2024	Assetmark Inc.	150,509	$29.72M	0.1%	+8.6%	0.009%
11/1/2024	Verdence Capital Advisors LLC	22,326	$4.41M	0.4%	+5.5%	0.001%
11/1/2024	Executive Wealth Management LLC	2,903	$0.57M	0.1%	+2.8%	0.000%
11/1/2024	Washington Trust Advisors Inc.	16,997	$3.36M	0.3%	+4.1%	0.001%
11/1/2024	United Bank	1,099	$0.22M	0.1%	N/A	0.000%
11/1/2024	Seascape Capital Management	27,111	$5.35M	1.9%	-2.4%	0.002%
11/1/2024	Windward Capital Management Co. CA	1,646	$0.33M	0.0%	N/A	0.000%
11/1/2024	Provident Trust Co.	11,322	$2.24M	0.0%	+2.3%	0.001%
11/1/2024	Shoker Investment Counsel Inc.	23,392	$4.62M	1.6%	-2.7%	0.001%
11/1/2024	Galvin Gaustad & Stein LLC	4,233	$0.84M	0.1%	+22.0%	0.000%
11/1/2024	Holistic Planning LLC	1,061	$0.21M	0.1%	N/A	0.000%
11/1/2024	CWA Asset Management Group LLC	55,651	$10.99M	0.6%	N/A	0.003%
11/1/2024	Equitable Trust Co.	34,226	$6.76M	0.4%	+8.6%	0.002%
11/1/2024	AEGON ASSET MANAGEMENT UK Plc	482,918	$95.15M	1.3%	-1.5%	0.027%
11/1/2024	Leavell Investment Management Inc.	79,045	$15.61M	0.8%	+11.4%	0.004%
11/1/2024	Fiera Capital Corp	59,628	$11.78M	0.0%	+6.1%	0.003%
11/1/2024	Hollencrest Capital Management	6,221	$1.23M	0.1%	-4.8%	0.000%
11/1/2024	ABLE Financial Group LLC	2,968	$0.59M	0.2%	-6.8%	0.000%
11/1/2024	Sonata Capital Group Inc.	1,824	$0.36M	0.2%	-18.7%	0.000%
11/1/2024	Capital Performance Advisors LLP	1,303	$0.26M	0.1%	+5.9%	0.000%
11/1/2024	Physicians Financial Services Inc.	12,095	$2.39M	0.7%	-3.6%	0.001%
11/1/2024	Granite Group Advisors LLC	8,073	$1.59M	1.0%	-32.9%	0.000%
11/1/2024	Heritage Wealth Management Inc.	24,278	$4.79M	1.6%	-0.6%	0.001%
11/1/2024	Gold Investment Management Ltd.	7,972	$1.56M	0.7%	-27.9%	0.000%
11/1/2024	Stiles Financial Services Inc	5,221	$1.03M	0.4%	-11.5%	0.000%
11/1/2024	AIA Group Ltd	37,073	$7.32M	0.2%	-22.7%	0.002%
11/1/2024	J.P. Marvel Investment Advisors LLC	85,671	$16.92M	2.8%	+0.5%	0.005%
11/1/2024	Summit Global Investments	11,646	$2.30M	0.1%	-9.6%	0.001%

Data available starting January 2016

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Today's Range

Now: $201.46

$198.35

$202.10

50 Day Range

MA: $194.18

$186.62

$203.87

52 Week Range

Now: $201.46

$135.85

$207.32

Volume

2,016,474 shs

Average Volume

5,305,519 shs

Market Capitalization

$355.85 billion

P/E Ratio

69.95

Dividend Yield

3.05%

Beta

0.63

Who are the company insiders with the largest holdings of AbbVie?: AbbVie's top insider investors include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Perry C Siatis (EVP)
Scott T Reents (CFO)
Timothy J Richmond (EVP)
Kevin K Buckbee (SVP)
Learn More about top insider investors at AbbVie.
Who are the major institutional investors of AbbVie?: AbbVie's top institutional shareholders include:
International Assets Investment Management LLC — 0.27%
Raymond James & Associates — 0.26%
Sumitomo Mitsui Trust Group Inc. — 0.23%
Robeco Institutional Asset Management B.V. — 0.20%
National Pension Service — 0.19%
DekaBank Deutsche Girozentrale — 0.17%
Learn More about top institutional investors of AbbVie stock.
Which major investors are selling AbbVie stock?: In the previous quarter, ABBV stock was sold by these institutional investors:
Artemis Investment Management LLP
DekaBank Deutsche Girozentrale
New York State Common Retirement Fund
Simplicity Wealth LLC
Argent Capital Management LLC
Exchange Traded Concepts LLC
Bleakley Financial Group LLC
Allspring Global Investments Holdings LLC
Within the previous year, company insiders that have sold AbbVie company stock include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Learn More investors selling AbbVie stock.
Which major investors are buying AbbVie stock?: In the previous quarter, ABBV stock was acquired by institutional investors including:
International Assets Investment Management LLC
Assenagon Asset Management S.A.
National Pension Service
Los Angeles Capital Management LLC
Principal Financial Group Inc.
Robeco Institutional Asset Management B.V.
Eastern Bank
Hamlin Capital Management LLC